Alert-Based Care for Pacemaker Patients

(RAPTOR - MAIN Trial)

This trial examines the effectiveness of two care approaches for individuals with pacemakers or defibrillators. Alert-based Care uses alerts to guide treatment, while Guideline-based Care follows standard guidelines. The trial aims to determine which method is safer and more effective. It may suit individuals with a wireless pacemaker or defibrillator who already use remote monitoring as part of their regular care. As an unphased trial, it provides a unique opportunity to contribute to research that could enhance future care strategies.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

Research has shown that using alerts to care for patients with pacemakers and defibrillators is generally safe. Studies have found that managing these devices through remote monitoring is effective and easy for patients to handle. For instance, a remote-first care model can streamline clinic operations and reduce unnecessary visits, indicating that patients usually encounter few problems with this method.

Researchers are excited about the trial of alert-based care for pacemaker patients because it offers a more tailored approach to managing heart devices. Unlike the traditional guideline-based care, which relies on routine transmissions and scheduled in-office check-ups, alert-based care focuses on real-time monitoring and management through wireless alerts. This proactive strategy could lead to earlier detection of issues and personalized treatment, potentially improving patient outcomes and reducing the need for frequent office visits.

This trial will compare Alert-based Care with Guideline-based Care for patients with wireless heart devices. Research has shown that using alerts to care for these patients appears promising. Remote monitoring, a key component of alert-based care, has proven effective and safe for tracking patients with devices like pacemakers and defibrillators. An international study found that 94.6% of scheduled data transmissions succeeded, indicating strong reliability. This approach may also enhance device clinic efficiency by reducing unnecessary visits. Although more information is needed, early findings suggest that alert-based care could improve management for patients with heart devices.¹²⁴⁶⁷